Cite
HARVARD Citation
Toscani, D. et al. (n.d.). The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors. Journal of bone and mineral research. pp. 815-827. [Online].